Suspected unexpected and other adverse reactions to antiretroviral drugs used as post-exposure prophylaxis of HIV infection - five-year experience from clinical practice.

about

Suspected unexpected and other adverse reactions to antiretroviral drugs used as post-exposure prophylaxis of HIV infection - five-year experience from clinical practice.

Item

http://www.wikidata.org/entity/Q55025502

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Suspected unexpected and other ...... rience from clinical practice.

@en

Suspected unexpected and other ...... rience from clinical practice.

@nl

type

Item

label

Suspected unexpected and other ...... rience from clinical practice.

@en

Suspected unexpected and other ...... rience from clinical practice.

@nl

prefLabel

Suspected unexpected and other ...... rience from clinical practice.

@en

Suspected unexpected and other ...... rience from clinical practice.

@nl

P1476

Suspected unexpected and other ...... rience from clinical practice.

@en

P2093

Andrzej Horban

http://www.w3.org/2001/XMLSchema#string

Ewa Firląg-Burkacka

http://www.w3.org/2001/XMLSchema#string

Ewa Pietraszkiewicz

http://www.w3.org/2001/XMLSchema#string

Justyna D Kowalska

http://www.w3.org/2001/XMLSchema#string

P2860

Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Prevention of HIV-1 infection with early antiretroviral therapy

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.

Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington.

Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.

P304

547-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2016.59701

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29765441

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5949906

http://www.w3.org/2001/XMLSchema#string